Product Program year 2025 Source: CMS Open Payments

Infectious Disease

Device Genetics

Open in the dashboard

General payments

$322,850

12 payments

Research payments

$0

0 payments

Through program year 2025, $322,850 in general payments and $0 in research payments were reported against Infectious Disease (Genetics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $290,152 6
2023 General $32,698 6

Breakdown

Who paid General payments · program years 2023–2025
  1. Illumina, Inc. $322,850 12 payments
Top recipients General payments · program year 2023
  1. Eric Topol Cardiovascular Disease · La Jolla, CA $22,990 70% · 2 payments
  2. Stuart Sealfon Neurology · New York, NY $5,857 18% · 2 payments
  3. Nathaly Sweeney Neonatal-Perinatal Medicine · La Jolla, CA $2,068 6% · 1 payment
  4. Jay Wohlgemuth General Practice · San Juan Capistrano, CA $1,783 5% · 1 payment

Each share is of general payments naming this product in 2023.

Specialties paid General payments · program year 2023
  1. Cardiovascular Disease Internal Medicine $22,990 70% · 1 practitioner
  2. Neurology Psychiatry & Neurology $5,857 18% · 1 practitioner
  3. Neonatal-Perinatal Medicine Pediatrics $2,068 6% · 1 practitioner
  4. General Practice $1,783 5% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. California $26,841 82% · 3 recipients
  2. New York $5,857 18% · 1 recipient

Each share is of general payments naming this product in 2023 where a state was reported.

12 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record